• CTC(CIRCULATING TUMOR CELL)

    are released from primary tumors and disseminated through the bloodstream,
    which possesses great metastatic potentials and results in poor clinical outcome

  • CTC-BASED LIQUID BIOPSY

    CytoGen's keen technology enables isolation of viable CTCs allowing subsequent molecular
    characterization of CTCs (including RNA, DNA, and protein levels), as well as CTC cultures

  • COMPANION DIAGNOSTICS

    Identification of genetic mutations in CTCs isolated serially from cancer
    patients provides guidance for the application of personalized medicine

CTC-based Liquid Biopsy Platform Cytogen provides diverse forms of applications and collaboration opportunities

GLOBAL TOP LIQUID BIOPSY COMPANY

Utilizing our extensive global collaboration and own LIQUID BIOPSY
PLATFORM developed with the integration of knowledge in bioscience
and engineering technology, CytoGen would contribute to the better
world by tackling cancer.

More

NEWS Latest news about CytoGen